Literature DB >> 34212406

The dilemma of treating the infected versus the wounded: Gaza's healthcare system is choked.

Alifiya Aamir1, Hashir Ali Awan1, Mufaddal Najmuddin Diwan1, Syeda Kanza Kazmi1, Mohammad Mehedi Hasan2, Zain Douba3, Irfan Ullah4.   

Abstract

Gaza has been facing persistent disturbance since the last 14 years. Even before the pandemic, Gaza faced a dire healthcare consequence with prevalent instability, lack of adequate medical resources, and limited health-related infrastructure. Gaza continued to struggle while responding to the pandemic as the other nearby countries. However, the challenges were compounded with the onset of the conflict that affected Gaza's infrastructure and displaced tens of thousands to make-shift shelters. The testing capacity of Gaza is alarmingly low that makes any outbreak difficult to document. Additionally, all medical centres have been affected by the ongoing conflict. These centres, if not directly impacted, are severely overwhelmed with those injured during the conflict, shifting focus and resources away from coronavirus. Vaccinations in Gaza cover only 1.9% of the population and a great number of unvaccinated people now may act as vectors of transmission in overcrowded shelters. Furthermore, non-availability of clean water to maintain hygienic conditions has heightened the risk of an explosive surge in cases. Hence, beyond the ceasefire, further steps need to be taken to strengthen Gazan response to COVID-19 pandemic.
© 2021 John Wiley & Sons Ltd.

Entities:  

Keywords:  COVID 19; challenges; clean water; healthcare system; testing capacity; vaccination

Year:  2021        PMID: 34212406     DOI: 10.1002/hpm.3274

Source DB:  PubMed          Journal:  Int J Health Plann Manage        ISSN: 0749-6753


  1 in total

1.  Ukraine's triple emergency: Food crisis amid conflicts and COVID-19 pandemic.

Authors:  Goodluck Nchasi; Carolyn Mwasha; Moshi Moshi Shaban; Rose Rwegasira; Benardine Mallilah; Joshua Chesco; Anastasiia Volkova; Ashraf Mahmoud
Journal:  Health Sci Rep       Date:  2022-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.